Published in

Wiley, British Journal of Haematology, 3(157), p. 331-338, 2012

DOI: 10.1111/j.1365-2141.2012.09047.x

Links

Tools

Export citation

Search in Google Scholar

Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.

Journal article published in 2012 by Daniele Campa, Alessandro Martino, Juan Sainz, Gabriele Buda, Krzysztof Jamroziak, Niels Weinhold, Rui Manuel Vieira Reis, Rui Manuel Vieira Reis, Ramón García-Sanz, Manuel Jurado, Rafael Ríos, Zofia Szemraj-Rogucka, Herlander Marques, Fabienne Lesueur, Peter Bugert and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Genome-wide association studies (GWAS) have shown that the 8q24 region harbours multiple independent cancer susceptibility loci, even though it is devoid of genes. Given that no GWAS data are currently available for multiple myeloma (MM), we tested the hypothesis that genetic variants in this region could play a role in MM risk. We genotyped 20 single nucleotide polymorphisms of 8q24 in 1188 MM cases and 2465 controls and found a statistically significant (P = 0*0022) association between rs2456449 and MM risk. These data provide further evidence that the genetic variability in the 8q24 region is associated with cancer risk, particularly haematological malignancies.